BAM
RDY icon

Blueshift Asset Management’s Dr. Reddy's Laboratories RDY Stock Holding History

Blueshift Asset Management’s Portfolio RDY Stock Details RDY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-22,470
Closed -$330K – 1252
2021
Q2 		$330K Buy
22,470
+1,165
+5% +$16.3K 0.02% 700
2021
Q1 		$262K Sell
21,305
-12,080
-36% -$155K 0.03% 685
2020
Q4 		$476K Buy
+33,385
New +$450K 0.06% 416
2020
Q1 		– Sell
-28,360
Closed -$230K – 579
2019
Q4 		$230K Buy
+28,360
New +$224K 0.03% 685

Other funds holding RDY

Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $304B AUM 35.64% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Blueshift Asset Management's RDY Position: Q3 2021 in Review

Blueshift Asset Management sold out of Dr. Reddy's Laboratories (RDY) in Q3 2021, closing a stake of 22,470 shares — an estimated $330K sold.

Blueshift Asset Management first reported a position in RDY in Q4 2019 and held it in 4 quarters. The position peaked at $476K in Q4 2020. 149 funds tracked by Wall St. Rank hold RDY as of Q3 2021.

  • Blueshift Asset Management reported no remaining Dr. Reddy's Laboratories position as of Q3 2021 after selling out during the quarter.
  • Blueshift Asset Management sold 22,470 Dr. Reddy's Laboratories shares in Q3 2021, an estimated $330K.
  • Blueshift Asset Management first reported a position in Dr. Reddy's Laboratories in Q4 2019 and held it in 4 quarters.
  • Blueshift Asset Management's Dr. Reddy's Laboratories position peaked at $476K in Q4 2020.
  • 149 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q3 2021.

Based on Blueshift Asset Management's 13F filing for Q3 2021, filed 12 Nov 2021.